Company Filing History:
Years Active: 2000-2017
Title: Innovations by Kuo-Fen Lee
Introduction
Kuo-Fen Lee is a prominent inventor based in Del Mar, CA (US). He has made significant contributions to the field of medical research, particularly in the treatment and prevention of neurodegenerative diseases. With a total of 6 patents, his work focuses on innovative methods that target critical health issues.
Latest Patents
Kuo-Fen Lee's latest patents include groundbreaking methods for the treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling. One of his notable inventions involves the administration of CRF-R1 selective antagonists and/or CRF-R2 selective agonists to reduce the accumulation of hyperphosphorylated tau protein in the central nervous system (CNS). This method aims to prevent the onset of Alzheimer's disease. Additionally, he has developed methods to increase insulin sensitivity or decrease insulin secretion by administering corticotropin-releasing factor receptor-2 inhibitors. These methods can be utilized to treat various metabolic diseases, including type 2 diabetes and obesity.
Career Highlights
Kuo-Fen Lee is associated with the Research Development Foundation, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on public health and the treatment of chronic diseases.
Collaborations
Kuo-Fen Lee collaborates with esteemed colleagues, including Wylie Walker Vale, Jr. and Tracy L. Bale, who contribute to his research endeavors.
Conclusion
Kuo-Fen Lee's innovative approaches to treating complex health issues highlight his role as a leading inventor in the medical field. His patents reflect a commitment to improving health outcomes through scientific research and innovation.